Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...
New theories suggest Alzheimer's may involve autoimmunity, with beta-amyloid linked to immune response misfires.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback